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Individual trajectories of asthma, obesity and ADHD during the 
transition from childhood and adolescence to young adulthood
Abstract
The German Health Interview and Examination Survey for Children and Adolescents (KiGGS) provides comprehensive 
and reliable data on the health situation of the upcoming generation. The KiGGS cohort accompanies participants from 
the KiGGS baseline study (2003–2006) into adulthood. Until now, two follow-up surveys of the cohort have been 
implemented with KiGGS Wave 1 (2009–2012) and KiGGS Wave 2 (2014–2017). In KiGGS Wave 2, the cohort was 
supplemented by the in-depth study ‘Family and care-specific factors influencing the development, trajectories and effects 
of mental disorders (especially ADHD), obesity and allergic diseases (especially asthma)’. One aim of the study was to 
identify individual trajectories of these health disorders. For this purpose, probabilities for typical transitions from the 
KiGGS baseline study to KiGGS Wave 2 were calculated. An important result is that many participants who had asthma, 
obesity or ADHD at KiGGS baseline still had the disease more than ten years later: Over a third still had asthma (35%) 
or ADHD (37%), and almost half were still affected by obesity (47%). The results point to the need for early preventive 
measures to stop these potentially chronic diseases from developing in childhood and adolescence.
  ASTHMA · OBESITY · ADHD · TRANSITION · YOUNG ADULTHOOD · KIGGS
proportion of these individuals continues to be affected 
by the condition into adulthood [3].
Bronchial asthma is the most common chronic disease 
in childhood and adolescence [6]. Asthma is an inflamma-
tory illness of the airways in which the bronchi overreact 
to physical, chemical, pharmacological or immunological 
stimuli (hyperreactivity) leading to variable narrowing of 
the airways (obstruction) [7]. Typical symptoms include 
whistling noises when breathing (wheezing), coughing, 
chest tightness and shortness of breath, all of which can 
be expressed in varying intensities and frequencies. In the 
majority of cases, asthma among children and adolescents 
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The majority of children and adolescents in Germany grow 
up healthy [1]. However, some of them are affected by 
chronic diseases. In most cases, these not only entail the 
need for regular health care, but are also accompanied by 
general and disease-specific stresses that are associated 
with special psychosocial demands for those affected and 
their families [2, 3]. The prevalence of chronic conditions 
in childhood and adolescence has increased worldwide 
[4]. In Germany, around every sixth girl and boy between 
the age of 0 and 17 years has a chronic disease [5]. A 
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is caused by allergies [8]. Allergic asthmatic reactions result 
from allergic sensitisations of the immune system. These 
conditions are often very stressful for children and adoles-
cents and their families and can have an impact on their 
emotional and physical well-being, as well as on school-
work and personal relationships [9].
The frequent occurrence of obesity in childhood and ado-
lescence is a global health problem and a major public health 
challenge for the 21st century [10]. Compared with their peers 
of normal weight, children and adolescents with obesity have 
reduced health-related quality of life and are at greater risk 
of increased blood pressure as well as lipid and glucose 
metabolism disorders [11, 12]. Furthermore, obesity among 
children and adolescents is associated with a greater likeli-
hood of type 2 diabetes, high blood pressure and cardiovas-
cular diseases in adulthood [13]. Children and adolescents 
with obesity may also face discrimination, bullying and stig-
matisation due to their body weight, and this can have long-
term consequences for their mental health [14, 15].
Attention deficit/hyperactivity disorder (ADHD) is the 
most commonly diagnosed behavioural disorder among 
children and adolescents, especially boys [16, 17]. The core 
symptoms of ADHD are inattention, hyperactivity and 
impulsivity. These symptoms usually begin in childhood, 
last longer than six months, occur in several areas of life, 
lead to noticeable suffering and severely limit a person’s 
everyday life [18]. The disorder can affect cognitive, aca-
demic and social development and pose major challenges 
to the family and social environment [16]. Children and 
adolescents with ADHD are also at higher risk for comor-
bid mental disorders and other health risks, such as sub-
stance use [19]. 
Data on chronic diseases in childhood and adolescence 
are regularly collected in the German Health Interview and 
Examination Survey for Children and Adolescents (KiGGS). 
The KiGGS baseline study (2003–2006) was the first to pro-
vide population-based, nationwide representative results 
on the prevalence of asthma, obesity and ADHD among 
girls and boys in Germany. KiGGS Wave 2 (2014–2017), con-
ducted around ten years later, provides the most current 
data available. The data show that 3.5% of 0- to 17-year-olds 
had asthma or were taking asthma medication in the twelve 
months prior to the survey, [20] and that 5.9% of 3- to 
17-year-olds are obese [21]. Compared to the KiGGS base-
line study, the prevalences of asthma (3.2%) and obesity 
(6.3%) have not changed significantly and remain on a high 
level – especially obesity. In contrast, parent-reported ADHD 
diagnoses declined over the decade between the KiGGS 
baseline study (5.3%) and KiGGS Wave 2 (4.4%) [22].
Data collected from repeated interviews and examina-
tions of participants who had previously taken part in the 
KiGGS baseline study enable analyses of health develop-
ments, trajectories and transitions to be conducted at the 
individual level (the longitudinal component of KiGGS) [23]. 
This data can be used to answer the question of the extent 
to which chronic diseases develop, decline or persist over 
a period of a good ten years (Info box). Using KiGGS cohort 
data, this article describes individual trajectories of asthma, 
obesity and ADHD during the transition from childhood 
and adolescence to young adulthood.
The KiGGS study  
The German Health Interview and Examination 
Survey for Children and Adolescents
Data owner: Robert Koch Institute
Aim: Providing reliable information on health 
status, health-related behaviour, living condi-
tions, protective and risk factors, and health 
care among children, adolescents and young 
adults living in Germany, with the possibility  
of trend and longitudinal analyses 
Study design: Combined cross-sectional and 
cohort study 
KiGGS survey waves:  
▶ KiGGS baseline study (2003–2006)  
 interview and examination survey
▶ KiGGS Wave 1 (2009–2012)  
 interview survey
▶ KiGGS Wave 2 (2014–2017)  
 interview and examination survey
KiGGS cross-sectional study
Population: Children and adolescents with  
permanent residence in Germany
Age range: 0–17 years
KiGGS cohort study
Sampling: Re-invitation of everyone who took 
part in the KiGGS baseline study (n = 17,641) 
and who was willing to participate in a follow-up
Age range KiGGS Wave 1:  
6–24 years (n = 11,992)
Age range KiGGS Wave 2:  
10–31 years (n = 10,853)
More information is available at 
www.kiggs-studie.de/english
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aged between 0 and 17 years who took part in the KiGGS 
baseline study (2003–2006; interview and examination sur-
vey) were interviewed and examined into young adulthood. 
The first follow-up took place in KiGGS Wave 1 (2009–2012) 
as a telephone survey [25], while the second follow-up – 
KiGGS Wave 2 (2014–2017) – was again conducted as an 
interview and examination survey [26] (Figure 1). KiGGS 
2. Methodology
2.1 Data base: the KiGGS cohort
The KiGGS study is a key source of information for com-
prehensive and reliable data on the health situation of the 
upcoming generation [24]. In the longitudinal component 
– the KiGGS cohort [23] – 17,640 children and adolescents 
Info box 
Incidence, remission and persistence
Longitudinal data can be used to illustrate individ-
ual trajectories and developments over time. In 
the course of time, a new occurrence (incidence), 
an improvement (remission) or no change (per-
sistence) of a condition can be observed.
Incidence: At the beginning of the observation, 
there are individuals who do not have a chronic 
disease, but they develop one during the obser-
vation period. 
Remission: At the beginning of the observation, 
there are individuals who are affected by a chron-
ic condition, but no longer did so during the obser-
vation period.
Persistence: At all observation periods, individu-
als have a chronic disease. 
Figure 1 
Study design of the KiGGS cohort
Source: Own diagram, 
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2.3 Indicators for trajectory description: asthma, obesity 
and ADHD 
The KiGGS baseline study and KiGGS Wave 2 collected data 
from parents about whether their children had been physi-
cian-diagnosed with asthma (ever in their life). Furthermore, 
it was asked whether the condition occurred in the twelve 
months before the survey, and whether asthma medication 
was used in the twelve months before the survey. This infor-
mation can be used to estimate lifetime and 12-month 
prevalence of asthma for both surveys [20]. This article 
focuses on the 12-month prevalence of asthma, compris-
ing both medical diagnoses as well as symptoms and/or 
medication use in the preceding twelve months prior to 
the survey.
The analyses for obesity are based on standardised 
measurements of body height and weight taken from the 
examinations conducted for the KiGGS baseline study and 
KiGGS Wave 2 [21]. Body mass index (BMI) is calculated 
using the ratio of body weight to height squared (kg/m2) 
[28]. Since the relationship between body height and weight 
changes due to growth in childhood and adolescence, no 
uniform cut-off can be used to define obesity for children 
and adolescents across all age groups. Instead, BMI per-
centile curves are used to classify an individual value which 
is considered relative to the BMI distribution in a defined 
group (reference population), considering age and gender. 
In Germany, obesity is defined using the Kromeyer-Hau-
schild percentile curves [29, 30]. Children and adolescents 
are classified as obese if their BMI is above the 97th per-
centile of the reference population after having accounted 
for the person’s age and sex. Percentiles for adults were 
Wave 2 was supplemented by the in-depth study ‘Family 
and care-specific factors influencing the development, 
trajectories and effects of mental disorders (especially 
ADHD), obesity and allergic diseases (especially asthma)’. 
One aim of the in-depth study was to identify trajectory 
patterns of these health disorders during the transition 
from childhood and adolescence to young adulthood. In 
the following, results based on the two interview and 
examination surveys – KiGGS baseline study and KiGGS 
Wave 2 – are presented. 
2.2 Study sample
The initial sample of the KiGGS cohort includes the 17,640 
children and adolescents aged between 0 to 17 years who 
took part in the KiGGS baseline study [27]. All participants 
from the KiGGS baseline study who agreed to be re-con-
tacted were invited to KiGGS Wave 2, regardless of their 
participation in KiGGS Wave 1. Individuals who had moved 
abroad or who could not be found already at the time of 
KiGGS Wave 1 were excluded from the invitation. At the 
time of KiGGS Wave 2, the cohort participants were aged 
between 10 and 28 years. Due to adjustments in the recruit-
ment process, a small number of adults were already 
between 29 and 31 years. A total of 10,853 persons (61.5% 
of the baseline sample) participated in the interviews for 
the cohort in KiGGS Wave 2. For 6,465 participants of the 
baseline sample (36.6%), additional examination data are 
available in KiGGS Wave 2 [27].
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(2003–2006) and KiGGS Wave 2 (2014–2017) were calcu-
lated for the incidence, remission and persistence/stabili-
ty of asthma, obesity and ADHD. Since the two surveys 
took place about ten years apart, the cumulative ten-year 
incidence, ten-year remission and ten-year persistence/sta-
bility are calculated. In the following, the terms incidence, 
remission and persistence or stability are used for better 
readability.
All percentages are reported with 95% confidence inter-
vals (95% CI). They represent the statistical uncertainty of 
the estimator. For this reason, percentages with two digits 
are presented without additional decimal place (e.g. 35%). 
A figure of 34.7% implies a precision, which cannot be con-
cluded from the data. Single-digits frequencies, however, are 
rounded to one decimal place so as to provide two signifi-
cant digits (e.g. 2.4%). This approach is supported by the 
fact that statistical uncertainty is lower at the borders of the 
distribution. A statistically significant difference between 
groups is assumed when p-values are smaller than 0.05.
Weighting factors are used to compensate for possible 
bias in the sample due to selective re-participation [26, 34]. 
The analyses are carried out using SAS (version 9.4) and 
Stata (version 15.1) with survey procedures that account 
for the study design and weighting.
With regard to asthma and ADHD, all analyses are car-
ried out separately for girls/women and boys/men in order 
to provide sex-specific results. However, age-dependent 
development is shown for obesity as there is a relation 
between body growth and puberty. These results build on 
the findings regarding the individual trajectories of obesity 
among preschool children published at the KiGGS Sympo-
sium in 2018 [35]. 
also published in Germany in 2015 [29]. Therefore, this per-
centile-based definition according to Kromeyer-Hauschild 
[29] was also used for the adult cohort in order to avoid 
methodological changes in the transition from adolescence 
to young adulthood. Children under two years of age were 
excluded from the analyses, because obesity is not defined 
as a disease at this age [31].
The indicator for ADHD is the parent-reported ADHD 
diagnosis which was ever made by a physician or psycholo-
gist [16, 32]. Participants aged 18 or above reported this 
diagnosis themselves. Although this information does not 
indicate whether the diagnoses reported in KiGGS were 
made in accordance with guidelines, the indicator proved 
reliable for children and adolescents aged between 3 and 
17 years in an international study [33]. If an ADHD diagno-
sis was reported both in the KiGGS baseline study and in 
KiGGS Wave 2, this article refers to the stability of the diag-
nosis report. The present indicator cannot be used to make 
any statements about the persistence of a clinical ADHD. 
Furthermore, no conclusions can be made about remission 
of ADHD, since the indicator used here depicts lifetime 
prevalence. In addition, it is questionable whether a neu-
robiological disorder such as ADHD can lead to remission 
or whether only symptom relief occurs.
2.4 Statistical analysis
The statistical analyses of transition probabilities are based 
on data from 8,594 persons from the age of three years for 
asthma; 5,447 persons from the age of two years for obesi-
ty and 6,773 persons from the age of three years for ADHD. 
Transition probabilities between the KiGGS baseline study 
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asthma medication when KiGGS Wave 2 was conducted 
(persistence).
Figure 2 shows the probabilities of asthma disease dur-
ing the transition from childhood and adolescence to young 
adulthood by sex. No statistically significant difference was 
identified between the sexes with regard to the incidence, 
remission and persistence of asthma.
With regard to obesity, Table 1 shows that around 5% of 
children and adolescents aged two years and older who 
were not affected by obesity in the KiGGS baseline study 
developed obesity over the following ten years (incidence). 
 3. Results
Of the children and adolescents aged three years or above 
without asthma at KiGGS baseline, 3.4% (95% CI: 2.9–4.0) 
had reported a medical diagnosis of asthma and current 
symptoms and/or asthma medication around ten years 
later (incidence). Of those who were asthmatic at KiGGS 
baseline, 65% (95% CI: 56–73) were free of symptoms and/
or medication around ten years later (remission). This 
means that slightly more than one third (35%, 95% CI: 
27–44) were still affected by asthma and/or were using 
Figure 2 
Individual 10-year trajectory of asthma by sex 
(n = 4,636 female, n = 3,958 male) 
Source: KiGGS baseline study (2003–2006), 
KiGGS Wave 2 (2014–2017)
Just over a third of children 
and adolescents with asthma 
at KiGGS baseline were still 
affected by the condition 
and/or were still using 
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dren who are not affected by obesity between the ages of 
two and six.
A little more than one third of 2- to 6-year-old children 
with obesity in the KiGGS baseline study were no longer 
obese ten years later; among 14- to 17-year-olds is the pro-
portion with 50% higher (remission). This means that 
around two thirds of 2- to 6-year-old children with obesity 
in the KiGGS baseline study were still affected by obesity 
around ten years later (persistence).
Table 2 shows that for 2.4% of participants aged three 
years or above whose parents did not report an ADHD 
diagnosis at the time of the KiGGS baseline study, an 
ADHD diagnosis was reported for the first time during the 
following ten years (incidence). This was more often true 
for male than for female participants. For slightly more 
than one third of the children and adolescents with par-
ent-reported ADHD diagnosis at KiGGS baseline, a diag-
nosis was reported again in KiGGS Wave 2. With regard 
to the stability of the ADHD diagnosis report, there are 
no differences by sex.
Just over half of the children and adolescents who were 
affected by obesity in the KiGGS baseline study were no 
longer obese ten years later (remission). Consequently, a 
little less than half of the participants remained in this cat-
egory when KiGGS Wave 2 was conducted (persistence).
The results stratified by age show that 6.7% of children 
aged between two and six years in the KiGGS baseline study 
developed obesity in the following ten-year period (inci-
dence). This applies to only 3.8% in the oldest age group 
of 14- to 17-year-olds (Table 1). Thus, the incidence of obe-
sity tends to decrease with increasing age. However, it 
should be noted that the proportion of children with obe-
sity in the KiGGS baseline study also increases with age. 
Adolescents who are not affected by obesity by the age of 
14 and 17 years are less likely to develop obesity than chil-
Table 1 
10-year individual trajectory of obesity 
(n = 5,447)
Source: KiGGS baseline study (2003–2006), 
KiGGS Wave 2 (2014–2017)
Age at  
KiGGS baseline
Cumulative 10-year incidence Cumulative 10-year remission Cumulative 10-year persistence
% (95% CI) % (95% CI) % (95% CI)
Total 5.1 (4.3–6.0) 53 (44–61) 47 (39–56)
2–6 years 6.7 (5.3–8.4) 35 (21–52) 65 (48–79)
7–10 years 4.9 (3.4–7.0) 57 (44–70) 43 (30–57)
11–13 years 4.5 (2.8–7.2) 63 (44–78) 37 (22–56)
14–17 years 3.8 (2.4–6.0) 50 (33–66) 50 (34–67)
CI = confidence interval
Table 2 
Incidence and stability of ADHD 
lifetime diagnoses by sex 
(n = 3,742 female, n = 3,031 male)
Source: KiGGS baseline study (2003–2006), 





% (95% CI) % (95% CI)
Total 2.4 (1.9–3.0) 37 (28–47)
Female 1.3 (0.9–2.0) 36 (22–53)
Male 3.6 (2.7–4.7) 38 (27–50)
CI = confidence interval
Almost 4% of children and 
adolescents without asthma 
at KiGGS baseline had been 
medically diagnosed with 
asthma for the first time 
during the following ten 
years and reported current 
symptoms and/or current 
asthma medication.
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West Germany; both started in 1995 [40]) should be men-
tioned. In contrast to the KiGGS cohort, which is based on 
a representative sample for Germany, it was particularly 
important for the intervention arms of the birth cohort 
studies to include newborns with an increased allergy risk. 
In the MAS study, asthma trajectories have been estimated 
stratified by family history of the condition. Children whose 
parents have allergies – asthma, allergic rhinitis or atopic 
dermatidis – were found to have a cumulative 20-year inci-
dence of about 40%; if only one parent had an allergy, this 
rate was 25%. Among children of nonallergic parents, the 
cumulative 20-year incidence reached a plateau of just over 
10% in early adolescence [41]. The GINI (plus) and LISA 
(plus) studies, which used data provided by parents on 
medical diagnoses, found that the prevalence of asthma 
increased during the first ten years of life. A cumulative 
10-year asthma incidence of approximately 3% to 4% can 
be derived from the two studies [40]. In line with the KiGGS 
study, the results on individual asthma trajectories show 
that a considerable proportion of children and adolescents 
become asthmatics and remain affected by the condition 
over a long period of their lives and continue to require 
therapy. Therefore, and also in view of the fact that asthma 
is often associated with other allergic diseases such as aller-
gic rhinitis and atopic dermatitis, the recently published 
National Asthma Care Guideline specifically addresses chil-
dren and adolescents [42].
Only a few prospective studies have examined the indi-
vidual trajectories of obesity in children and adolescents 
in Germany [43–45]. These studies indicate a high level of 
persistence and incidence and a low level of remission 
among primary school children. Thus, obesity among this 
4. Discussion
Data from the KiGGS study show that a notable propor-
tion of children and adolescents living in Germany are 
affected by asthma, obesity or ADHD [20–22]. The aim of 
the present article was to quantify patterns of these select-
ed chronic diseases in the transition from childhood and 
adolescence to young adulthood.
Data from the KiGGS cohort indicate that slightly more 
than one third of the children and adolescents who had a 
medical asthma diagnosis at KiGGS baseline and who 
reported symptoms and/or had taken medication for the 
condition in the preceding twelve months prior to the sur-
vey were still affected by asthma when KiGGS Wave 2 was 
conducted. 3.4% of children and adolescents without 
asthma at KiGGS baseline had been medically diagnosed 
with asthma for the first time during the following ten years 
and reported current symptoms and/or current medication. 
It is difficult to compare these results with those of other 
national or international longitudinal studies in children 
and adolescents. There are major differences between the 
studies in study design, specific study question, inclusion 
criteria (e.g. with regard to age), follow-up time and base-
line time. Especially in Europe, several population-based 
birth cohort studies have been established so far, aiming, 
among other things, to investigate asthma trajectories 
[36–38]. In Germany, the MAS study (Multicentre Allergy 
Study; started in 1990 [39]), the GINI (plus) study (Ger-
man Infant Nutritional Intervention plus environmental 
and genetic influences on allergy development) and the 
LISA (plus) study (Influence of Life-style Factors on Devel-
opment of the Immune System and Allergies in East and 
About half of the children 
and adolescents with obesity 
at KiGGS baseline were no 
longer affected by obesity 
around ten years later.
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many. Data from the KiGGS cohort show that 2.4% of the 
children and adolescents who participated in the KiGGS 
baseline study were diagnosed with ADHD for the first time 
during the next ten years. As expected, for more than one 
third of the children and adolescents with an ADHD diag-
nosis report at the time of the KiGGS baseline study, a cor-
responding diagnosis was also reported a good ten years 
later. It can be assumed that the group of participants with 
a stable diagnostic report is also more affected by persis-
tent ADHD symptoms and that the probability of persistent 
trajectories is increased in this group. This is supported by 
the fact that this group had higher symptom burdens in 
psychopathological screening in both the KiGGS baseline 
study and KiGGS Wave 1 [50]. An American study that exam-
ined the stability of ADHD diagnoses over a comparable 
period of eleven years came to similar stability rates of clin-
ical ADHD diagnoses as the KiGGS cohort with the ADHD 
diagnosis report, reporting a persistence rate of 35% [51]. 
The KiGGS study, as a nationwide representative health 
survey, provides valuable, unique data for the assessment 
of disease incidence for common chronic diseases among 
children and adolescents such as asthma, obesity and 
ADHD at the population level. An important finding of 
the cohort is that many participants in the KiGGS base-
line study (2003–2006) with asthma, obesity or ADHD 
were still affected by the condition around ten years later. 
Slightly more than one third of those affected by asthma 
(35%) or ADHD (37%) reported the same condition in 
KiGGS Wave 2 (2014–2017); for obesity, it was even almost 
half (47%). On the other hand, only a few participants of 
the KiGGS baseline study developed one of these chronic 
diseases during the following ten years (2.4% ADHD, 3.4% 
age group often persists through adolescence into adult-
hood. In addition, many children and adolescents develop 
obesity with increasing age, while only a relatively small 
number of children with obesity in primary school return 
to a normal weight. A study from the United States indi-
cates that children who are affected by obesity when they 
start school do not tend to be affected temporarily [46]. The 
transition between normal weight, overweight and obesity 
is more flexible among preschool children, but even at this 
age, only a small number of children with obesity returns 
to normal weight later in life. The KiGGS cohort confirms 
these findings and indicates that obesity among children 
of preschool age often persists into adolescence and young 
adulthood. Consequently, preventive measures should also 
be targeted at children of nursery and primary school age 
[21]. A high level of persistence has been found for obesity 
among school-aged children, although incidence decreases 
with age [47, 48]. As such, obesity is more likely to persist 
with increasing age, but the number of adolescents with 
incident obesity does not increase in the same extent as in 
younger ages. This is also confirmed by the KiGGS cohort: 
overall, the proportion of children and adolescents with 
obesity increases but the proportion of incident cases 
seems to decrease with increasing age. Furthermore, the 
results of the KiGGS cohort suggest that obesity persis-
tence tends to decrease and remission tends to increase 
up to puberty. Thus, the time frame until puberty seems to 
be reasonable to prevent obesity (for obesity prevention 
see also the current S3 guideline ‘Therapy and prevention 
of obesity in childhood and adolescence’ [49]).
The trajectory of ADHD, especially during the transition 
to young adulthood, has so far been little studied in Ger-
Obesity among preschool 
aged children often  
persists into adolescence 
and young adulthood.
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Universitätsmedizin Berlin’s ethics committee assessed the 
ethics of the KiGGS baseline study (No. 101/2000) and 
Hannover Medical School’s ethics committee assessed 
KiGGS Wave 2 (No. 2275-2014); both committees provided 
their approval for the respective studies. Participation in 
the studies was voluntary. The participants and/or their par-
ents/legal guardians were also informed about the aims 
and contents of the study and about data protection. 
Informed consent was obtained in writing.
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KiGGS cohort, once case definitions in the routine data 
have been validated [52], the data could be used to associ-
ate complex trajectories across the lifespan with baseline 
conditions in childhood and adolescence and health out-
comes in adulthood. 
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